Filing Flows › Companies › Orthofix Medical › Cash flow
Orthofix Medical cash flow, quarter by quarter
Latest: Q2 FY26 · from the cash-flow statements filed with the SEC
Free cash flow−$18.9M in Q2 FY26
Analysis
In Q2 FY26, Orthofix Medical generated −$6.2M of operating cash flow and spent $12.6M on capital projects, leaving free cash flow of −$18.9M. That is $23.4M less than in Q2 FY25 ($4.5M).
Operating cash flow was −$6.2M against net income of −$15.8M. The largest differences: other liabilities −$17.6M, depreciation & amortization +$13.3M, inventory −$12.1M.
Its cash conversion cycle was 240 days (receivables 59 + inventory 269 − payables 88).
Free cash flow
Cash runway and the debt wall
Orthofix Medical is burning cash: its operations consume cash, a free cash flow of −$75.5M a year at the current rate against $104M of cash and investments: a runway of about 17 months before any new financing.
Where the cash came from and went
From profit to cash
| Quarter | Receivable days | Inventory days | Payable days | Cash conversion cycle |
|---|---|---|---|---|
| Q2 FY26 | 59 | 269 | 88 | 240 |
| Q1 FY26 | 63 | 276 | 89 | 249 |
| Q4 FY25 | 56 | 251 | 79 | 228 |
| Q3 FY25 | 58 | 280 | 77 | 261 |
| Q2 FY25 | 59 | 249 | 65 | 243 |
| Q1 FY25 | 62 | 227 | 59 | 231 |
| Q4 FY24 | 55 | 272 | 66 | 261 |
| Q3 FY24 | 59 | 311 | 73 | 297 |
Every quarter
| Quarter | Operating cash flow | Capital spending | Net borrowing (+) / repaid (−) | Shares issued | Cash drawn (+) / kept (−) | Free cash flow |
|---|---|---|---|---|---|---|
| Q2 FY26 | −$6.2M | −$12.6M | −$25K | — | $16.5M | −$18.9M |
| Q1 FY26 | −$17.6M | −$10.7M | $64.0M | — | −$35.8M | −$28.3M |
| Q4 FY25 | $27.7M | −$10.9M | −$198K | $2.8M | −$19.2M | $16.8M |
| Q3 FY25 | $12.4M | −$9.9M | −$189K | $36K | $2.7M | $2.5M |
| Q2 FY25 | $11.6M | −$7.1M | −$187K | $3.0M | −$8.2M | $4.5M |
| Q1 FY25 | −$18.4M | −$6.7M | −$188K | $49K | $25.3M | −$25.1M |
| Q4 FY24 | $23.7M | −$8.5M | $29.9M | $2.9M | −$53.2M | $15.2M |
| Q3 FY24 | $11.7M | −$5.8M | −$179K | $120K | −$3.7M | $5.9M |
Orthofix Medical: income statement and cash flow
Orthofix Medical, Q2 FY26: revenue $211M (+4% year over year), operating margin -3.9%. The chart follows the revenue to costs, profit and cash.
Orthofix Medical: every quarter, Q/Q and Y/Y → Open in the app
Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.